| Panel |
|---|
| borderColor | #ccc |
|---|
| bgColor | #D8D8D8 |
|---|
| titleBGColor | #D0D0D0 |
|---|
| borderStyle | solid |
|---|
| title | Table of Contents |
|---|
|
|
...
| Panel |
|---|
| borderColor | #CCFFFF |
|---|
| bgColor | #CCFFFF |
|---|
| titleBGColor | #99FFFF |
|---|
| borderStyle | solid |
|---|
|
Rules Based on Patient's Age
- If a patient is >= 19 years and did NOT complete the series before 19 years of age, then the Recommendation is Conditional and the reason code is HIGH_RISK.6
- Shots administered to a patient who is >= 19 years and < 22 years of age will continue to be evaluated (based on minimum intervals) and, if valid, will count toward completion of the series.
- If a patient's age at administration is >= 22 years and the patient did NOT complete the series before 22 years of age, then the Evaluation is Accepted and the reason code is ABOVE_REC_AGE_SERIES. (Shots administered to a patient >= 22 years of age do NOT count toward completion of the series; the series can NOT be completed once the patient is >= 22 years old.)
| Anchor |
|---|
| Completion Special Rule |
|---|
| Completion Special Rule |
|---|
|
Series Completion Special Rule
- Once a patient completes the MCV4 2-dose series the Recommendation is Not Recommended and the reason code is COMPLETE_HIGH_RISK.5 (Meningococcal should never have a recommendation of Not Recommended/Complete.)
|
...
CVX Code | Name | Absolute Minimum Age |
|---|
114 | Meningococcal MCV4P (Menactra) | 9 months - 4 days |
136 | Meningococcal MCV4O (Menveo) | 2 months - 4 days |
| 32 | Meningococcal MPSV4 (Menomune)
| 2 years - 4 days |
108 | Meningococcal, unspecified formulation | 2 years - 4 days4 |
| 147 | Meningococcal MCV4, unspecified formulation | 9 months - 4 days4 |
| 203 | Meningococcal MenACWY-TT (MenQuadfi) | 2 years - 4 days |
| Panel |
|---|
| borderColor | #CCFFFF |
|---|
| bgColor | #CCFFFF |
|---|
| titleBGColor | #99FFFF |
|---|
| borderStyle | solid |
|---|
|
CVX Code Specific RulesCVX Code Absolute Minimum Age |
...
This is a 2-dose series, except when the Meningococcal ACWY Vaccine Group MCV4 2-Dose Series Exception Rule applies. This series, however, will never have a forecast of "Complete"; see the Meningococcal ACWY Vaccine Group Series Completion Special Rule.
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum
Age | Minimum Age | Routine
Age | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
|---|
1 | MCV4 2-dose | 10 years | 11 years | 11 years | 13 years + 4 weeks | 114, 136, 108, 147, 32, 203 | N/A |
2 | MCV4 2-dose | 16 years - 4 days | 16 years | 16 years
| 17 years + 4 weeks | 114, 136, 108, 147, 32, 203 | N/A |
Vaccine Dose Parameters - Minimum and Recommended Intervals
...
| Panel |
|---|
| borderColor | #CCFFFF |
|---|
| bgColor | #CCFFFF |
|---|
| titleBGColor | #99FFFF |
|---|
| borderStyle | solid |
|---|
|
Series Special Rules Shots Administered Below Series Recommended Age for Dose 1
If a shot of meningococcal is given below the series absolute minimum age (10 years), and above the CVX minimum age, then the Evaluation is accepted and the reason code is BELOW_REC_AGE_SERIES.3 Shots that are accepted do not count toward the series.
| Anchor |
|---|
| MCV4 Exception Rule |
|---|
| MCV4 Exception Rule |
|---|
|
MCV4 2-Dose Series Exception Rule
|
...
| Panel |
|---|
| borderColor | #FDF5E6 |
|---|
| bgColor | #FDF5E6 |
|---|
| titleBGColor | #FAEBD7 |
|---|
| borderStyle | solid |
|---|
|
Notes- The recommended interval between dose 1 and dose 2 in the table above (56 days)2 differs from the CDC CDSi recommended interval of 4 years. While the recommended intervals differ, in practice ICE and CDC CDSi will come up with the same recommended due date. CDC CDSi only uses the recommended interval when the recommended age is not provided. See the CDC CDSi Logic Specification for details on how they calculate their recommended due date.
- Although shots administered below the series absolute minimum age are evaluated as Accepted3 rather than Invalid, the ICE general rule for Shots Administered Below Series Minimum Age for Dose 1 still applies. No minimum or recommended interval applies from the meningococcal shot given below the series absolute minimum age to target dose 1.
- A shot of meningococcal administered below the series absolute minimum age should never be evaluated as Invalid/Below Minimum Age Series.
|